mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.005 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.005 |
mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.007 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.007 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.007 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
0.13 |
0.008 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.009 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.01 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |